ArticleScientific reports2019
MEK inhibition enhances the response to tyrosine kinase inhibitors in acute myeloid leukemia.
María Luz Morales et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it